Target intelligence / Profile preview

Aquaporin-5 (AQP5)

Target
AQP5
Molecular classification
Transporter, Water channel protein, Major intrinsic protein (MIP) family
01

Overview

Aquaporin-5 (AQP5) is a small integral membrane protein (265 amino acids, ≈28 kDa) that forms water-selective channels within cell membranes[2][5][6]. It is one of the major aquaporins in mammals, predominantly expressed in secretory glands (such as salivary, lacrimal, and sweat glands), lung airway epithelium, stomach, pancreas, and other tissues[6][9]. AQP5 assembles as a homotetramer in the membrane, with each monomer containing six transmembrane α-helices and a characteristic NPA (asparagine–proline–alanine) motif forming the water-selective pore[1][2][3][5][6]. Its physiological function is the rapid and selective transport of water across epithelial cell membranes, enabling high-capacity fluid secretion in saliva, tears, and pulmonary secretions[2][3][9]. AQP5 expression and membrane localization is regulated by phosphorylation and trafficking, which can be altered in various diseases. Abnormal AQP5 activity or localization is implicated in numerous pathological states, including several cancer types (where it can act as a biomarker of aggressiveness and possibly promote tumor cell survival and migration), cystic fibrosis-associated lung disease, and Sjögren’s syndrome[7][9]. No clinically approved drugs currently target AQP5 directly, though it remains a potential therapeutic target in cancer and glandular disorders.

Other names
Aquaporin 5AQP-5Water channel protein AQP-5
02

Mechanism of action

Modulation of water channel activity (e.g., via channel blockade or by altering membrane trafficking). Experimental small-molecule AQP inhibitors target the water channel pore or block trafficking to the membrane[7].

03

Biological functions

Transmembrane water transportSaliva secretionTear secretionPulmonary/airway secretionRegulation of glandular fluid secretion
04

Disease associations

CancerPulmonary disease (e.g., cystic fibrosis-related lung dysfunction)Sjögren’s syndrome (dry mouth/eyes)Other glandular dysfunctions
05

Safety considerations

Risk of disrupting physiologic water balance in secretory tissues (e.g., potential for dry mouth, impaired tear secretion, airway dehydration)Potential systemic fluid balance effects if substantially inhibited[7]
06

Interacting drugs

None widely approved or clinically established as direct modulators; experimental AQP inhibitors have been proposed, but no specific approved drugs are known to directly target Aquaporin-5[7].
07

Biomarkers

AQP5 expression level (as biomarker for cancer progression, tumor aggressiveness, or glandular function)[7]

Beyond the preview

Go deeper on Aquaporin-5 (AQP5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aquaporin-5 (AQP5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call